Healthcare >> Sector Roundtables >> September 28, 1998
WILLIAM SLATTERY is a Partner at Deerfield Management Company covering
the biotechnology and healthcare based Internet technologies. He began
his career at the laboratory bench, studying complications associated
with End Stage Renal Disease. Mr. Slattery was previously associated
with Amerindo Investment Advisors, Inc., National Medicine Enterprises,
Lifescan/Johnson & Johnson and HMSS, a division of Secomerica. He
received a BSc degree in Biochemistry from the State University of New
York at Albany and attended the Graduate School of Health at Rutgers. Profile
MARGARET H. MALLOY is a Senior Analyst at Hambrecht & Quist. Previously,
she was associated with Needhan & Co. and PaineWebber. She also
conducted research in the field of brain asymmetry and endocrinology at
the University of Chicago. Ms. Malloy earned her Bachelor's degree from
the University of Chicago and is a Chartered Financial Analyst. Profile
JEFFREY W. CASDIN is a Chief Executive Officer, Principal at Cooper Hill
Partners, LLC, covering the biotechnology industry. He was previously
associated with Merrill Lynch and Oppenheimer & Company, Inc. He
received a ScB in Electrical Engineering, an AB degree from Brown
University and an MBA with High Distinction from Harvard University
Graduate School of Business where he was a Baker Scholar. Mr. Casdin is
a member of the Board of the National Genome Resource Center in Santa
Fe, New Mexico and he is also the Publisher of Biotech Investor, an
investment newsletter. Profile
ELISE T. WANG is currently a Managing Director in Equity Research at
Salomon Smith Barney covering the biotechnology industry. Previously,
she was a Managing Director and Senior Research Analyst in the Health
Care Equity Research Group at PaineWebber Incorporated, covering the
biotechnology industry. In 2000, Ms. Wang was voted runner-up in the
Institutional Investor poll in Biotechnology. In addition, Ms. Wang also
achieved recognition in the Wall Street Journal All Star Analyst survey
in Biotechnology for the past three years. Prior to joining Equity
Research at PaineWebber in January of 1996, she was a Vice President in
the Health Sciences Group of the Investment Banking Division of
PaineWebber with responsibility for providing financial advisory work
and services in biotechnology and other healthcare sectors. Ms. Wang
holds a Bachelor of Arts degree in Engineering Sciences with a specialty
in Biomechanics from Harvard University and a Master of Business
Administration degree from Harvard Graduate School of Business. Profile
CRAIG PARKER is Vice President and Biotechnology Analyst at Donaldson,
Lufkin & Jenrette. Previously, he was associated with J.P. Morgan & Co.
He earned his Bachelor's degree from the University of Chicago and his
M.B.A. from the University of Michigan. Mr. Parker is married and
includes bicycle racing and backpacking among his personal interests. Profile
stocks in 1998 year to date. To what extent did the group participate in
the gains made by the overall market in the first
